# CLINICAL LOGIC: LIBRARY DESIGN & QUESTION SELECTION
## Comprehensive Rationale for All Intake Form Decisions

**Version:** 1.0
**Last Updated:** November 25, 2025
**Purpose:** Document clinical reasoning for every decision in the intake form design
**Audience:** Clinical team, business development, IT/dev team

---

## üìã TABLE OF CONTENTS

1. [Overview: Evidence-Based Selection Methodology](#methodology)
2. [Family History: Why 15 Items](#family-history)
3. [Surgical History: Why 40 Items](#surgical-history)
4. [Allergy History: Why 31 Items](#allergy-history)
5. [Medical History: Why 132 Items](#medical-history)
6. [Lifestyle Questions: Why These 11 Questions](#lifestyle-questions)
7. [Missing Lists & Recommended Additions](#missing-lists)
8. [Free-Text Reduction Strategy](#free-text-strategy)
9. [Converting Free-Text to Structured Data](#free-text-conversion)

---

<a name="methodology"></a>
## 1. OVERVIEW: EVIDENCE-BASED SELECTION METHODOLOGY

### Selection Criteria for All Lists

Every item across all libraries was selected using these 5 criteria:

| Criterion | Weight | Definition | Example |
|-----------|--------|------------|---------|
| **1. Prevalence** | 30% | How common is this in the US population? | Hypertension (47% adults) = HIGH priority |
| **2. Clinical Impact** | 35% | Does this significantly affect morbidity/mortality or dashboard scores? | Family history of early MI = HIGH impact |
| **3. Actionability** | 20% | Does knowing this change clinical management? | BRCA gene carrier ‚Üí Prophylactic screening = ACTIONABLE |
| **4. Score Modifier Magnitude** | 10% | Does this create ‚â•5 point adjustment in any domain? | Post-CABG = -15 Cardio-Structure = SIGNIFICANT |
| **5. Safety/Legal Risk** | 5% | Is this required for patient safety or medicolegal protection? | Latex allergy before surgery = CRITICAL |

### Tier 1 vs. Tier 2 Philosophy

**Tier 1 Items:**
- Cover 80-90% of patient population
- Pre-defined checkboxes with structured expansion questions
- Direct mapping to score modifiers
- Auto-populate clinical alerts and monitoring needs

**Tier 2 Items:**
- Rare conditions (<2% prevalence)
- Free-text capture with clinical review required
- Manual score modifier assignment
- Flagged for clinician evaluation

### Target: 80/20 Rule

**Goal:** 80% of clinical value from 20% of possible questions

- **Personal Medical History:** 132 diagnoses (vs. 10,000+ ICD-10 codes) = Top 1.3%
- **Family History:** 15 conditions (vs. 100+ hereditary conditions) = Top 15%
- **Surgical History:** 40 procedures (vs. 3,000+ CPT codes) = Top 1.3%
- **Allergies:** 31 allergies (vs. 1,000+ possible allergens) = Top 3%

---

<a name="family-history"></a>
## 2. FAMILY HISTORY: WHY 15 ITEMS?

### Clinical Reasoning: Focus on Hereditary Risk with HIGH Penetrance

**Why only 15 vs. 132 medical history items?**

Family history serves a **different clinical purpose** than personal history:
- **Personal history** = Actual disease present ‚Üí Immediate score modifiers, treatment monitoring
- **Family history** = Future risk prediction ‚Üí Preventive screening, genetic counseling

**Selection Logic:**
Only include family history items where:
1. **Strong genetic component** (heritability >30%)
2. **Actionable intervention** exists (screening, prophylaxis, genetic testing)
3. **Relative risk** increases by ‚â•2x with positive family history
4. **Age threshold** matters (early-onset disease more significant)

---

### The 15 Selected Conditions - Clinical Justification

#### CARDIOVASCULAR/METABOLIC (5 items)

| Condition | Heritability | Relative Risk with FHx | Actionable Intervention | Why Include |
|-----------|--------------|------------------------|------------------------|-------------|
| **1. Early Heart Attack** | 40-60% | 1.5-2.5x | Lipid screening age 20, statin therapy, aspirin | #1 cause of death, strong genetic component |
| **2. Early Stroke** | 30-40% | 1.3-2.0x | BP control, anticoagulation (AFib screening) | Preventable with BP/AFib management |
| **3. Familial Hypercholesterolemia** | 50% (autosomal dominant) | 3-13x MI risk | Aggressive statin therapy, age 8-10 screening | Treatable, early intervention prevents MI |
| **4. Sudden Cardiac Death <50** | 50-70% (channelopathies) | 5-10x | Genetic testing, ICD placement, activity restriction | Life-saving intervention available |
| **5. Type 2 Diabetes** | 40% | 2-6x (multiple relatives) | Early A1C screening, lifestyle modification | Most common metabolic disease, preventable |

**Why NOT include:** Varicose veins (low impact), peripheral artery disease (covered under early CAD), hypertension (weak genetic component, environmental)

---

#### CANCER (6 items)

| Condition | Heritability | Relative Risk with FHx | Actionable Intervention | Why Include |
|-----------|--------------|------------------------|------------------------|-------------|
| **6. Breast Cancer <50** | 15-20% (BRCA: 55-85% lifetime risk) | 2x (1st degree), 4-5x (BRCA) | Mammogram age 40 vs. 50, MRI, prophylactic mastectomy | #1 female cancer, highly actionable |
| **7. Ovarian Cancer** | 10-15% (BRCA: 40% lifetime risk) | 3-4x | BRCA testing, prophylactic oophorectomy age 35-40 | Deadly, preventable with surgery |
| **8. Colon Cancer <50** | 35% (Lynch: 80% lifetime risk) | 2-3x (1st degree), 10x (Lynch) | Colonoscopy age 40 vs. 45, Lynch testing | Highly preventable with screening |
| **9. Prostate Cancer** | 42% | 2x (1 relative), 5x (2+ relatives) | PSA screening age 40-45, genetic testing | #1 male cancer, screening age varies |
| **10. Pancreatic Cancer** | 10% | 2-3x | Enhanced surveillance (EUS/MRI) for high-risk | Deadly, new screening for high-risk families |
| **11. Melanoma** | 10% | 2-3x | Annual derm exams, genetic testing (CDKN2A) | Preventable with early detection |

**Why NOT include:** Cervical cancer (viral, not genetic), bladder cancer (low heritability), stomach cancer (rare in US), liver cancer (mostly environmental)

---

#### NEUROLOGICAL (1 item)

| Condition | Heritability | Relative Risk with FHx | Actionable Intervention | Why Include |
|-----------|--------------|------------------------|------------------------|-------------|
| **12. Early Alzheimer's <65** | 60-80% (early-onset) | 3-5x | Genetic testing, cognitive screening, clinical trial enrollment | Major cause of disability, trials available |

**Why only 1 neuro item?** Most neurological diseases (Parkinson's, MS, ALS) have weak genetic components or no preventive interventions

---

#### RENAL (1 item)

| Condition | Heritability | Relative Risk with FHx | Actionable Intervention | Why Include |
|-----------|--------------|------------------------|------------------------|-------------|
| **13. Polycystic Kidney Disease** | 50% (autosomal dominant) | 50% if parent affected | BP control, genetic testing, family planning | Common hereditary kidney disease, actionable |

**Why NOT include:** General "kidney disease" (mostly acquired), kidney stones (weak genetic component)

---

#### IMMUNE/OTHER (2 items)

| Condition | Heritability | Relative Risk with FHx | Actionable Intervention | Why Include |
|-----------|--------------|------------------------|------------------------|-------------|
| **14. Autoimmune Diseases** | 20-50% (varies) | 2-10x (varies by disease) | Early symptom monitoring, avoid triggers | Clustered in families, early treatment improves outcomes |
| **15. Osteoporosis with Fracture <50** | 50-80% | 2-3x | DEXA screening age 50 vs. 65, calcium/vitamin D | Preventable fractures, modifiable risk |

---

### Why NOT More Family History Items?

**Considered but excluded:**

| Condition | Why Excluded |
|-----------|--------------|
| Asthma | Weak heritability, environmental triggers dominant |
| Migraine | Limited actionable interventions beyond what patient already knows |
| Depression/Anxiety | Complex polygenic inheritance, limited prevention |
| Obesity | Environmental factors dominate, patient already knows own weight |
| COPD | 90% smoking-related, not genetic screening target |
| Arthritis | Age-related, weak genetic component |
| Glaucoma | Should be included in future expansion (hereditary, actionable) |
| Aneurysms | Should be included in future expansion (hereditary, screenable) |

---

<a name="surgical-history"></a>
## 3. SURGICAL HISTORY: WHY 40 ITEMS?

### Clinical Reasoning: Surgical History as Diagnosis Proxy

**Key Insight:** Surgical history serves THREE purposes:
1. **Diagnosis Inference:** Surgery implies underlying diagnosis (CABG ‚Üí CAD)
2. **Anatomical Changes:** Affects interpretation of future tests/exams
3. **Monitoring Needs:** Post-surgical surveillance requirements

### Selection Criteria (40 procedures chosen from 3,000+ CPT codes)

| Criterion | Threshold | Examples Meeting Criteria |
|-----------|-----------|---------------------------|
| **Prevalence** | >0.5% of US adults | Hip replacement (1M/year), gallbladder removal (600K/year) |
| **Diagnosis Link** | Links to ‚â•1 Tier 1 diagnosis | CABG ‚Üí CAD, mastectomy ‚Üí breast cancer |
| **Score Modifier** | Creates ‚â•5 point adjustment | CABG = -15 Cardio-Structure |
| **Monitoring Impact** | Requires ongoing surveillance | Post-transplant ‚Üí lifelong immunosuppression monitoring |
| **Test Interpretation** | Changes normal values/imaging | Hysterectomy ‚Üí can't get uterine cancer, bariatric surgery ‚Üí different malabsorption rules |

---

### The 40 Selected Procedures - By System

#### CARDIOVASCULAR (8 procedures) - 23% of US adults >65 have CAD

| Surgery | Annual US Volume | Linked Diagnosis | Score Modifier | Why Include |
|---------|------------------|------------------|----------------|-------------|
| CABG | 200K/year | CAD (always) | -15 Cardio-Structure | Major cardiac surgery, lifelong monitoring |
| Coronary Stent | 500K/year | CAD (always) | -10 Cardio-Structure | Very common, dual antiplatelet therapy |
| Valve Replacement | 90K/year | Valvular disease | -12 Cardio-Function | Anticoagulation, endocarditis prophylaxis |
| Pacemaker/ICD | 225K/year | Arrhythmia, heart failure | -10 Cardio-Function | Device checks, MRI restrictions |
| Carotid Endarterectomy | 140K/year | Stroke, carotid stenosis | -10 Neuro-Risk | Stroke prevention, vascular disease marker |
| Aneurysm Repair | 50K/year | Aortic aneurysm | -15 Cardio-Structure | Imaging surveillance |
| Peripheral Bypass | 60K/year | PAD | -8 Cardio-Risk | Vascular disease marker |
| ASD/VSD Repair | Rare but important | Congenital heart disease | -10 Cardio-Structure | Endocarditis prophylaxis, MRI considerations |

**Why NOT include:** Varicose vein stripping (cosmetic/minor), arteriovenous fistula (covered under dialysis/CKD diagnosis)

---

#### ORTHOPEDIC (8 procedures) - 7M orthopedic surgeries/year in US

| Surgery | Annual US Volume | Linked Diagnosis | Score Modifier | Why Include |
|---------|------------------|------------------|----------------|-------------|
| Hip Replacement | 450K/year | Osteoarthritis | -8 MSK-Function | Very common, lifelong DVT/dislocation risk |
| Knee Replacement | 750K/year | Osteoarthritis | -8 MSK-Function | #1 joint replacement, functional limitations |
| Spinal Fusion | 400K/year | Degenerative disc, stenosis | -10 MSK-Function, -8 Neuro-Function | Chronic pain, narcotic use common |
| Shoulder Replacement | 70K/year | Arthritis, rotator cuff | -6 MSK-Function | Increasing prevalence, functional impact |
| ACL Repair | 200K/year | Sports injury | -4 MSK-Function | Young patients, re-injury risk, early arthritis |
| Spinal Laminectomy | 300K/year | Stenosis, herniated disc | -6 Neuro-Function | Nerve compression history |
| Rotator Cuff Repair | 250K/year | Rotator cuff tear | -4 MSK-Function | Common, re-tear risk |
| Carpal Tunnel Release | 500K/year | Carpal tunnel syndrome | -2 Neuro-Function | Very common, minimal score impact but high prevalence |

**Why NOT include:** Bunion surgery (cosmetic/minor), trigger finger release (minor), ankle surgery (less common)

---

#### ABDOMINAL (8 procedures) - GI surgeries very common

| Surgery | Annual US Volume | Linked Diagnosis | Score Modifier | Why Include |
|---------|------------------|------------------|----------------|-------------|
| Appendectomy | 280K/year | Appendicitis (resolved) | 0 | Very common, minimal long-term impact but asked frequently |
| Gallbladder Removal | 600K/year | Cholelithiasis | -2 Metabolic-Function | Extremely common, bile acid malabsorption |
| Hernia Repair | 800K/year | Inguinal/ventral hernia | -2 MSK-Structure | Very common, recurrence risk |
| Bariatric Surgery | 250K/year | Obesity, diabetes | -10 Metabolic-Function (but IMPROVES over time) | Major metabolic impact, micronutrient deficiencies |
| Colonoscopy + Polypectomy | 15M colonoscopies/year, ~30% have polyps | Colon polyps | -4 Metabolic-Risk | Cancer screening, surveillance schedule changes |
| Bowel Resection | 150K/year | Crohn's, cancer, diverticulitis | -8 Metabolic-Function | Malabsorption, short bowel syndrome |
| Liver Resection | 30K/year | Liver cancer, metastases | -12 Metabolic-Function | Cancer surveillance, liver function monitoring |
| Colostomy/Ileostomy | 100K/year | IBD, cancer, diverticulitis | -10 Metabolic-Function | Quality of life, electrolyte monitoring |

**Why NOT include:** Hemorrhoidectomy (minor), pilonidal cyst (minor), umbilical hernia repair (usually minor)

---

#### CANCER (6 procedures) - 1.9M cancer diagnoses/year

| Surgery | Annual US Volume | Linked Diagnosis | Score Modifier | Why Include |
|---------|------------------|------------------|----------------|-------------|
| Mastectomy | 100K/year | Breast cancer | -6 Immune-Risk (cancer history) | Common cancer, surveillance schedule |
| Lumpectomy | 150K/year | Breast cancer | -6 Immune-Risk | Less invasive than mastectomy, radiation often follows |
| Prostatectomy | 80K/year | Prostate cancer | -6 Immune-Risk, -4 Repro-Function | #1 male cancer surgery, ED/incontinence common |
| Colon Resection (cancer) | 70K/year | Colon cancer | -8 Immune-Risk, -6 Metabolic-Function | Covered above, but cancer-specific |
| Hysterectomy (cancer) | 40K/year (cancer-related) | Endometrial/cervical cancer | -6 Immune-Risk | Cancer surveillance |
| Thyroidectomy (cancer) | 30K/year | Thyroid cancer | -6 Immune-Risk, -8 Repro-Function (hypothyroid) | Lifelong thyroid replacement |

**Why NOT include:** Skin cancer excisions (too common, low impact unless melanoma), orchiectomy (rare)

---

#### TRANSPLANT (4 procedures) - 40K transplants/year

| Surgery | Annual US Volume | Linked Diagnosis | Score Modifier | Why Include |
|---------|------------------|------------------|----------------|-------------|
| Kidney Transplant | 25K/year | ESRD | -12 Renal-Function (IMPROVES from dialysis baseline) | Lifelong immunosuppression, frequent labs |
| Liver Transplant | 9K/year | Cirrhosis, liver failure | -15 Metabolic-Function (IMPROVES from pre-transplant) | Immunosuppression, cancer risk |
| Heart Transplant | 3.5K/year | Heart failure | -20 Cardio-Function (IMPROVES significantly) | Immunosuppression, frequent biopsies |
| Lung Transplant | 2.5K/year | COPD, pulmonary fibrosis | -18 Resp-Function (IMPROVES from baseline) | Immunosuppression, infection risk |

**Why include low-volume surgeries?** Transplant = massive clinical impact, intensive monitoring, high medication burden

---

#### WOMEN'S HEALTH (3 procedures) - Hysterectomy alone = 600K/year

| Surgery | Annual US Volume | Linked Diagnosis | Score Modifier | Why Include |
|---------|------------------|------------------|----------------|-------------|
| Hysterectomy (non-cancer) | 560K/year | Fibroids, endometriosis, bleeding | -4 Repro-Function | Very common, hormone changes, can't get uterine cancer |
| C-Section | 1.2M/year (32% of births) | Obstetric indication | 0 (no long-term impact) | Extremely common, asked frequently, VBAC considerations |
| Oophorectomy | 300K/year | Ovarian cysts, cancer prevention | -8 Repro-Function (surgical menopause if bilateral) | Hormone replacement, osteoporosis risk |

**Why NOT include:** Tubal ligation (no score impact), D&C (minor procedure), laparoscopy (diagnostic, not definitive surgery)

---

#### OTHER HIGH-IMPACT (3 procedures)

| Surgery | Annual US Volume | Linked Diagnosis | Score Modifier | Why Include |
|---------|------------------|------------------|----------------|-------------|
| Cataract Surgery | 4M/year | Cataracts | 0 | #1 surgery in US, very low impact but universally asked |
| Tonsillectomy | 500K/year | Recurrent tonsillitis | 0 | Very common (esp. childhood), minimal adult impact |
| Dialysis Access (AV fistula) | 100K/year | ESRD | Covered under CKD diagnosis | Indicates dialysis dependence |

---

### Why 40 is the Right Number

**Coverage Analysis:**
- 40 procedures capture **~85-90% of surgeries** patients report
- Covers all major organ systems
- Balances comprehensiveness with form length

**What's in Tier 2 (Free-Text):**
- Rare surgeries (<10K/year): Whipple procedure, esophagectomy, craniotomy
- Cosmetic procedures: Rhinoplasty, breast augmentation
- Minor procedures: Skin tag removal, wart removal

---

<a name="allergy-history"></a>
## 4. ALLERGY HISTORY: WHY 31 ITEMS?

### Clinical Reasoning: Safety First, Then Prescribing Efficiency

**Purpose of Allergy List:**
1. **Patient Safety** (Primary) - Prevent anaphylaxis, adverse reactions
2. **Prescribing Efficiency** - EMR auto-alerts, alternative medication suggestions
3. **Procedural Safety** - Latex, contrast, anesthesia flags before procedures

### Selection Criteria

| Criterion | Threshold | Examples |
|-----------|-----------|----------|
| **Prevalence** | >0.5% of population | Penicillin allergy: 10% report it (1% true allergy) |
| **Severity Risk** | Potential for anaphylaxis or severe reaction | Peanuts, shellfish, penicillin |
| **Prescribing Frequency** | Drug prescribed >1M times/year | Antibiotics, NSAIDs, ACE inhibitors |
| **Cross-Reactivity** | Allergy affects multiple related drugs | Penicillin ‚Üí cephalosporins |
| **Procedural Impact** | Required screening before common procedures | Contrast dye before CT, latex before surgery |

---

### The 31 Selected Allergies - Clinical Justification

#### DRUG ALLERGIES (18 items)

**ANTIBIOTICS (5 items)** - Most commonly prescribed drug class

| Allergy | Reported Prevalence | True Allergy Rate | Why Include |
|---------|---------------------|-------------------|-------------|
| **Penicillin** | 10% report | 1% confirmed | #1 reported allergy, affects multiple antibiotics, often false (childhood rash) |
| **Sulfa drugs** | 3-8% | 1-3% | Common UTI/MRSA antibiotic (Bactrim), important to distinguish from sulfonylureas |
| **Cephalosporins** | 2-3% | 1% | 10% cross-reactivity with penicillin (overstated historically) |
| **Macrolides** | 1-2% | <1% | Z-pack very common, often reported as "allergy" when just GI upset |
| **Fluoroquinolones** | 1-2% | <1% | Cipro/Levaquin common, FDA warnings (tendon rupture), important to document |

**NSAIDs/ANALGESICS (4 items)** - Most commonly used OTC medications

| Allergy | Reported Prevalence | True Allergy Rate | Why Include |
|---------|---------------------|-------------------|-------------|
| **Aspirin** | 0.6-2.5% | 0.3-0.9% | Cardio-protective (MI/stroke), cross-reacts with NSAIDs, desensitization possible |
| **Ibuprofen/NSAIDs** | 2-3% | 0.5-1% | OTC pain management, alternative needed (acetaminophen) |
| **Acetaminophen** | <1% | 0.01% (very rare) | Only non-NSAID OTC option, true allergy extremely rare |
| **Codeine** | 5-10% report | <1% true allergy | Common opioid, often side effects (nausea) misreported as allergy |

**OTHER OPIOIDS (2 items)**

| Allergy | Why Include |
|---------|-------------|
| **Morphine** | Hospital standard opioid, chemically distinct from others |
| **Oxycodone/Hydrocodone** | Most prescribed outpatient opioids (Percocet, Vicodin) |

**CARDIOVASCULAR DRUGS (3 items)** - Chronic disease medications

| Allergy | Prevalence | Why Include |
|---------|------------|-------------|
| **ACE inhibitors** | 10-15% get cough, 0.1-0.7% angioedema | Very common BP med (lisinopril), angioedema = life-threatening |
| **Statins** | 10-15% report myalgias | #1 prescribed drug class, "allergy" usually myalgias (try different statin) |
| **Beta-blockers** | 5-10% side effects | Common for BP/heart, side effects often misreported as allergy |

**METABOLIC DRUGS (2 items)**

| Allergy | Why Include |
|---------|-------------|
| **Metformin** | #1 diabetes drug, GI side effects common (not allergy), but need alternatives |
| **Insulin** | Essential for Type 1 diabetes, true allergy rare but critical to identify |

**OTHER (2 items)**

| Allergy | Why Include |
|---------|-------------|
| **Local anesthetics** | Required for dental/minor procedures, most are vasovagal reactions (not allergy) |
| **Corticosteroids** | True allergy extremely rare, but side effects often severe |

---

#### FOOD ALLERGIES (8 items) - "Big 9" Allergens

**FDA-Required Labeling (Top 9):** Account for 90% of food allergies

| Food | Prevalence | Anaphylaxis Risk | Why Include |
|------|------------|------------------|-------------|
| **Peanuts** | 1-2% adults, 2-3% children | HIGH (50-60% have severe reactions) | #1 cause of food allergy death |
| **Tree nuts** | 0.5-1% adults | HIGH | Often co-occurs with peanut allergy |
| **Shellfish** | 2-3% adults | HIGH | Most common adult-onset food allergy |
| **Fish** | 0.4% adults | MODERATE-HIGH | Different allergen than shellfish |
| **Milk** | 2-3% children, <1% adults | LOW-MODERATE in adults | Distinguish from lactose intolerance (not allergy) |
| **Eggs** | 1-2% children, <1% adults | LOW-MODERATE in adults | Vaccine considerations (flu shot) |
| **Wheat** | 0.4% adults | MODERATE | Distinguish from celiac (autoimmune) vs. allergy vs. sensitivity |
| **Soy** | 0.3% adults | LOW-MODERATE | Common in processed foods, vegetarian protein source |

**Not included:** Sesame (9th FDA allergen, lower prevalence), mustard, lupin (rare in US)

---

#### ENVIRONMENTAL/PROCEDURAL (5 items)

| Allergy | Prevalence | Why Include |
|---------|------------|-------------|
| **Latex** | 1-6% general population, 10-30% healthcare workers | Life-threatening during surgery, all procedures must use latex-free equipment |
| **Iodinated contrast dye** | 1-3% have reactions | Required for CT scans, pre-medication protocol exists |
| **Gadolinium (MRI contrast)** | 0.01-0.1% | Alternative to CT contrast, different allergen (no cross-reactivity) |
| **General anesthesia** | Variable (true allergy rare) | Malignant hyperthermia (genetic, 1:100K) is life-threatening, requires anesthesiology consult |
| **Adhesive/tape** | 1-3% | Wound care, post-surgical comfort, hypoallergenic alternatives available |

---

### Why 31 is the Right Number

**Coverage:**
- 18 drugs cover **95% of commonly prescribed medications**
- 8 foods cover **90% of food allergies** (FDA "Big 9")
- 5 environmental cover **all critical procedural safety issues**

**Tier 2 (Free-Text) Captures:**
- Rare drugs: Intravenous contrast agents, chemotherapy, biologics
- Uncommon foods: Sesame, mustard, specific fruits
- Environmental: Specific plants, insect stings (could be added)

---

<a name="medical-history"></a>
## 5. MEDICAL HISTORY: WHY 132 ITEMS?

### Clinical Reasoning: Balancing Comprehensiveness with Usability

**Why 132 conditions?**

The existing Medical History Tier 1 Library was designed to capture:
- **80-90% of chronic disease burden** in US adults
- All conditions with **score modifiers ‚â•5 points** in any domain
- All conditions requiring **context rule adjustments** (e.g., diabetic HbA1c targets)

### Breakdown by Prevalence

| Prevalence Tier | # of Conditions | Examples | Rationale |
|-----------------|-----------------|----------|-----------|
| **Very Common (>10% US adults)** | 15 | Hypertension (47%), obesity (42%), high cholesterol (38%), diabetes (11%), depression (21%) | Core of patient population |
| **Common (3-10%)** | 35 | Asthma (8%), COPD (6%), CKD (15%), heart disease (6.7%), stroke (3%) | Major chronic diseases |
| **Moderate (1-3%)** | 50 | Rheumatoid arthritis (1.3%), lupus (0.1% but 1.5% in Black women), IBD (1.3%), heart failure (2.3%) | Significant score modifiers |
| **Less Common (<1%)** | 32 | Parkinson's (0.3%), MS (0.3%), specific cancers | High impact conditions despite low prevalence |

### Evidence: NHANES & CDC Data

**Top 20 Chronic Conditions (NHANES 2017-2020):**

1. Hypertension - 47% ‚úÖ Included
2. Obesity - 42% ‚úÖ Included
3. High cholesterol - 38% ‚úÖ Included
4. Arthritis - 23% ‚úÖ Included (OA, RA)
5. Depression - 21% ‚úÖ Included
6. Diabetes - 11% ‚úÖ Included (Type 1, Type 2, pre-diabetes)
7. Chronic kidney disease - 15% ‚úÖ Included
8. Asthma - 8% ‚úÖ Included
9. COPD - 6% ‚úÖ Included
10. Coronary artery disease - 6.7% ‚úÖ Included
11. Heart failure - 2.3% ‚úÖ Included
12. Stroke - 3% ‚úÖ Included
13. Cancer (any) - 6% ‚úÖ Included (multiple types)
14. Atrial fibrillation - 2-3% ‚úÖ Included
15. Osteoporosis - 10% (women >50) ‚úÖ Included
16. GERD - 20% ‚úÖ Included
17. Sleep apnea - 9% ‚úÖ Included
18. Chronic pain - 20% ‚úÖ Included (fibromyalgia, back pain)
19. Migraine - 15% ‚úÖ Included
20. Thyroid disease - 5% ‚úÖ Included

**All top 20 conditions are covered in the 132-item library.**

---

<a name="lifestyle-questions"></a>
## 6. LIFESTYLE QUESTIONS: WHY THESE 11 QUESTIONS?

### Clinical Reasoning: Evidence-Based Mortality & Morbidity Predictors

The 11 lifestyle questions were selected from the existing **Lifestyle Pillar Questionnaires v2.1** based on:
1. **Strongest mortality predictors** (all-cause mortality hazard ratios)
2. **Most actionable** (modifiable behaviors)
3. **Fastest to answer** (for 5-10 minute form constraint)

---

### THE 11 SELECTED QUESTIONS - EVIDENCE BASE

#### NUTRITION PILLAR (3 questions)

| Question | Evidence Base | Hazard Ratio / Impact | Why Include |
|----------|---------------|----------------------|-------------|
| **1. Fruit & vegetable intake** | 10+ servings/day reduces all-cause mortality by 31% (BMJ 2014) | HR 0.69 for high vs. low intake | Strongest dietary predictor, widely actionable |
| **2. Water intake** | Chronic dehydration linked to CKD, heart failure, cognitive decline | Biomarker for overall health behaviors | Simple, modifiable, affects multiple systems |
| **3. Alcohol consumption** | >14 drinks/week (women) or >21 (men) ‚Üí 1.5-2x mortality risk | HR 1.5-2.0 for heavy use | #3 preventable cause of death, liver disease, cancer, accidents |

**Why NOT included in quick form:**
- Processed food intake (covered in full 85-question assessment)
- Sugar intake (covered in full assessment)
- Meal timing (lower impact, less evidence)

**Mortality Impact:** Nutrition accounts for **~20% of preventable deaths** (poor diet = 678K deaths/year in US)

---

#### MOVEMENT PILLAR (2 questions)

| Question | Evidence Base | Hazard Ratio / Impact | Why Include |
|----------|---------------|----------------------|-------------|
| **4. Aerobic exercise (days/week)** | 150 min/week reduces all-cause mortality by 31% (Lancet 2016) | HR 0.69 for active vs. sedentary | #1 modifiable lifestyle factor for longevity |
| **5. Sitting time (hours/day)** | >8 hours sitting ‚Üí 1.2-1.5x mortality risk (independent of exercise!) | HR 1.2-1.5 | Emerging risk factor, distinct from exercise |

**Why NOT included:**
- Strength training (important but lower mortality impact than aerobic)
- Flexibility (lower impact)
- Screen time (captured in full assessment)

**Mortality Impact:** Physical inactivity = **~10% of preventable deaths** (~200K/year)

**Key Evidence:** Sitting time is an **independent risk factor** - you can exercise 1 hour/day and still have increased mortality if you sit 10+ hours/day (Mayo Clinic 2015)

---

#### RECOVERY PILLAR (2 questions)

| Question | Evidence Base | Hazard Ratio / Impact | Why Include |
|----------|---------------|----------------------|-------------|
| **6. Sleep duration (hours/night)** | <6 hours or >9 hours ‚Üí 1.3x mortality risk (Sleep 2010) | HR 1.3 for short sleepers, HR 1.3 for long sleepers (U-shaped curve) | Strong mortality predictor, modifiable |
| **7. Stress level (0-10 scale)** | High chronic stress ‚Üí 1.4-1.6x CVD risk, immune suppression | HR 1.4-1.6 for high stress | Allostatic load, affects all organ systems |

**Why NOT included:**
- Sleep quality (subjective, harder to quantify)
- Recovery practices (lower evidence base)

**Mortality Impact:** Sleep deprivation linked to **obesity, diabetes, CVD, Alzheimer's**

---

#### EMOTIONAL WELLNESS PILLAR (2 questions)

| Question | Evidence Base | Hazard Ratio / Impact | Why Include |
|----------|---------------|----------------------|-------------|
| **8. Depression screening (PHQ-2: "felt down/depressed")** | Depression ‚Üí 1.5-2x all-cause mortality, 2-3x CVD mortality | HR 1.5-2.0 | #1 mental health condition (21% prevalence), treatable |
| **9. Anxiety screening (GAD-2: "felt nervous/anxious")** | Anxiety ‚Üí 1.4x CVD mortality, immune suppression | HR 1.4 | High prevalence (19%), affects treatment adherence |

**Why NOT included:**
- Sense of purpose (important but harder to intervene on quickly)
- Social support (captured in environmental pillar)

**Mortality Impact:** Depression is an **independent CVD risk factor** (AHA 2014 scientific statement)

**Clinical Utility:** PHQ-2 and GAD-2 are **validated 2-question screeners** (sensitivity 83-95%, specificity 90%)

---

#### ENVIRONMENTAL/SOCIAL PILLAR (2 questions)

| Question | Evidence Base | Hazard Ratio / Impact | Why Include |
|----------|---------------|----------------------|-------------|
| **10. Social connection** | Social isolation ‚Üí 1.5x mortality risk (equivalent to smoking 15 cigarettes/day!) | HR 1.5 for isolated vs. connected | **Strongest psychosocial mortality predictor** (Holt-Lunstad meta-analysis 2010) |
| **11. Tobacco/smoke exposure** | Smoking ‚Üí 2-3x mortality risk, secondhand smoke ‚Üí 1.2-1.3x risk | HR 2-3 for active smoking | #1 preventable cause of death (480K deaths/year) |

**Why NOT included:**
- Housing stability (important for social determinants, but lower direct mortality impact)
- Access to nature (lower evidence base)
- Substance use (captured in full assessment)

**Mortality Impact:** Social isolation = **comparable to smoking** in mortality risk (meta-analysis of 148 studies, 300K participants)

---

### EVIDENCE SUMMARY: Why These 11?

**Ranked by All-Cause Mortality Impact (Hazard Ratios):**

| Rank | Lifestyle Factor | Hazard Ratio | Deaths/Year (US) |
|------|------------------|--------------|------------------|
| 1 | **Tobacco use** | 2.0-3.0 | 480,000 |
| 2 | **Poor diet** | 1.5-2.0 | 678,000 |
| 3 | **Physical inactivity** | 1.3-1.5 | 200,000 |
| 4 | **Social isolation** | 1.5 | Not quantified but significant |
| 5 | **Depression** | 1.5-2.0 | Contributes to ~67K suicides/year |
| 6 | **Anxiety** | 1.4 | Indirect (CVD, immune) |
| 7 | **Chronic stress** | 1.4-1.6 | Indirect (CVD, immune) |
| 8 | **Sleep deprivation** | 1.3 | Indirect (accidents, CVD) |
| 9 | **Excessive sitting** | 1.2-1.5 | Emerging evidence |
| 10 | **Alcohol (heavy use)** | 1.5-2.0 | 95,000 |

**All 11 questions target factors in the top 10 mortality predictors.**

---

### Why NOT Include More Lifestyle Questions in Quick Form?

The full **Lifestyle Pillar Questionnaires v2.1** has **85 questions** across 5 pillars.

**For the 5-10 minute intake form, we selected:**
- **2-3 questions per pillar** = 11 total
- **Highest-yield questions** (mortality impact + actionability)
- **Fastest to answer** (0-10 scales, no free-text)

**Other important questions saved for full assessment:**
- Detailed nutrition (processed foods, sugar, micronutrients)
- Strength training, flexibility
- Sleep quality, sleep hygiene
- Sense of purpose, resilience
- Housing stability, financial stress, environmental toxins

---

<a name="missing-lists"></a>
## 7. MISSING LISTS & RECOMMENDED ADDITIONS

### Current Intake Form Structure

‚úÖ **Currently Included:**
1. Basic Information (demographics)
2. Lifestyle Questions (11 items)
3. Medical History (132 diagnoses)
4. Family History (15 conditions)
5. Surgical History (40 procedures)
6. Allergies (31 allergies)
7. Medications (photo upload or free-text)

---

### RECOMMENDED ADDITIONS (Priority Order)

#### üî¥ **PRIORITY 1: MEDICATION HISTORY** (Currently optional - should be required)

**Why Critical:**
- Infers diagnoses not explicitly reported
- Identifies polypharmacy risk (>5 meds = 1.5x adverse events)
- Drug-drug interactions
- Medication adherence assessment

**Proposed Structure:**
- Photo upload (preferred) ‚Üê Already in mockup
- OR: Medication reconciliation list (import from pharmacy)
- OR: Free-text entry (last resort)

**Score Modifiers:**
- Polypharmacy (>5 meds) ‚Üí -5 All-Systems-Risk
- High-risk medications (opioids, anticoagulants, immunosuppressants) ‚Üí Specific alerts

**Clinical Impact:** Medication errors = 7K-9K deaths/year (JAMA), polypharmacy = major geriatric syndrome

---

#### üü° **PRIORITY 2: IMMUNIZATION HISTORY**

**Why Important:**
- Preventive care measure
- Identifies immunocompromised patients (no live vaccines)
- Public health reporting
- Dashboard "Preventive Care Score"

**Proposed Items (8 questions):**

| Vaccine | Target Population | Why Include |
|---------|------------------|-------------|
| **Flu (current season)** | All adults annually | Most common vaccine, annual reminder |
| **COVID-19 (up to date)** | All adults | Current pandemic, booster schedule changes |
| **Tdap (last 10 years)** | All adults | Tetanus/diphtheria/pertussis, required for wound care |
| **Shingles (Shingrix)** | Age 50+ | 90% effective, reduces severe pain |
| **Pneumococcal** | Age 65+ or high-risk | Prevents pneumonia deaths |
| **Hepatitis B** | Healthcare workers, high-risk | Occupational exposure |
| **MMR** | Adults born after 1957 without immunity | Measles outbreaks increasing |
| **HPV** | Age 9-45 | Cancer prevention (cervical, oropharyngeal) |

**Dashboard Integration:**
- Preventive Care Score (0-100)
- Yellow alerts for overdue vaccines
- Auto-schedule vaccine recommendations

**Estimated Time:** 1-2 minutes (simple checkboxes)

---

#### üü° **PRIORITY 3: SOCIAL DETERMINANTS OF HEALTH (SDOH)**

**Why Important:**
- SDOH account for **80% of health outcomes** (WHO)
- Required for value-based care, CMS quality metrics
- Identifies high-risk patients needing social services

**Proposed Items (5 questions - "PRAPARE" screening tool):**

| Question | Why Include |
|----------|-------------|
| **Housing stability** | Homelessness ‚Üí 3-4x mortality risk |
| **Food security** | Food insecurity ‚Üí 1.5x diabetes, 2x HTN |
| **Transportation** | Missed appointments, medication non-adherence |
| **Utilities (heat/electric)** | Chronic stress, medication storage (insulin) |
| **Safety concerns** | Domestic violence screening, neighborhood safety |

**Dashboard Integration:**
- SDOH Risk Score
- Auto-referrals to social work, community resources

**Estimated Time:** 1 minute

**Clinical Impact:** Food insecurity alone affects **10% of US households**, strongly predicts diabetes and CVD

---

#### üü¢ **PRIORITY 4: FUNCTIONAL STATUS**

**Why Important:**
- **Activities of Daily Living (ADLs)** = strongest predictor of hospitalization, mortality in older adults
- Identifies frailty (1.3-2x mortality risk)
- Guides care planning (home health, PT/OT referrals)

**Proposed Items (6 questions - Katz ADL + 3 IADLs):**

**Basic ADLs (Katz Index):**
1. Bathing - Independent / Need help / Dependent
2. Dressing - Independent / Need help / Dependent
3. Transferring (bed to chair) - Independent / Need help / Dependent
4. Toileting - Independent / Need help / Dependent
5. Eating - Independent / Need help / Dependent

**Instrumental ADLs (most impactful 3):**
6. Managing medications - Independent / Need help / Dependent
7. Managing finances - Independent / Need help / Dependent
8. Preparing meals - Independent / Need help / Dependent

**Score Modifiers:**
- 1-2 ADL dependencies ‚Üí -10 MSK-Function, -5 Neuro-Function
- 3+ ADL dependencies ‚Üí -20 MSK-Function, -10 Neuro-Function

**Dashboard Integration:**
- Functional Status Score
- Auto-referrals to PT/OT
- Fall risk assessment

**Estimated Time:** 1 minute

**Target Population:** Age 65+, or any age with chronic conditions

**Clinical Impact:** ADL dependency is **the strongest predictor of nursing home placement** and 1-year mortality

---

#### üü¢ **PRIORITY 5: REPRODUCTIVE HEALTH (Women)**

**Why Important:**
- Pregnancy status changes ALL normal ranges and score modifiers
- Menopause affects bone density, CVD risk
- Contraception affects medication choices (some teratogenic)

**Proposed Items (4 questions for women age 18-60):**

| Question | Why Include |
|----------|-------------|
| **Currently pregnant?** | Changes ALL normal ranges, many medications contraindicated |
| **Breastfeeding?** | Affects medication choices, caloric needs |
| **Menstrual status** | Regular / Irregular / Menopause ‚Üí Affects hormone levels, bone density |
| **Contraception use** | Drug interactions (antibiotics reduce OCP efficacy), planning considerations |

**Score Modifiers:**
- Pregnancy ‚Üí Separate "Pregnancy Dashboard" (different normal ranges)
- Menopause ‚Üí -5 MSK-Structure (osteoporosis risk), context rules for lipids

**Estimated Time:** 30 seconds

**Clinical Impact:** **Failure to identify pregnancy = major medication safety risk** (ACE inhibitors, statins, isotretinoin all teratogenic)

---

#### üü¢ **PRIORITY 6: SUBSTANCE USE HISTORY (Detailed)**

**Why Important:**
- Quick form only asks alcohol frequency
- Need to screen for **alcohol use disorder, drug use, injection drug use**
- Affects liver function, infection risk (HIV, HCV), mental health

**Proposed Items (4 questions - AUDIT-C for alcohol, NIDA Quick Screen):**

**Alcohol (AUDIT-C - validated 3-question screen):**
1. How often do you have a drink containing alcohol? (Already in quick form)
2. How many drinks containing alcohol do you have on a typical day?
   - 1-2 / 3-4 / 5-6 / 7-9 / 10+
3. How often do you have 6 or more drinks on one occasion?
   - Never / Less than monthly / Monthly / Weekly / Daily

**Drug Use (NIDA Quick Screen):**
4. In the past year, how often have you used:
   - Marijuana/cannabis
   - Cocaine/crack
   - Prescription opioids (not as prescribed)
   - Methamphetamine
   - Heroin or injection drugs

   (Never / Once or twice / Monthly / Weekly / Daily)

**Score Modifiers:**
- Alcohol use disorder (AUDIT-C ‚â•4 men, ‚â•3 women) ‚Üí -10 Metabolic-Function (liver), -5 Neuro-Function
- Injection drug use ‚Üí -12 Immune-Risk (HIV/HCV risk), +CRITICAL ALERT for infectious disease screening

**Dashboard Integration:**
- Substance Use Disorder screening positive ‚Üí Auto-referral to addiction medicine
- Critical alert for HCV, HIV screening if injection drug use

**Estimated Time:** 1-2 minutes

**Clinical Impact:** **22M Americans have substance use disorder**, only 10% receive treatment

---

### SUMMARY: Recommended Missing Lists

| List | Priority | # Questions | Time | Impact |
|------|----------|-------------|------|--------|
| **Medications** | üî¥ HIGH | Photo or list | 10 sec - 3 min | CRITICAL - already in mockup, make required |
| **Immunizations** | üü° MEDIUM | 8 | 1-2 min | Preventive care score, public health |
| **SDOH** | üü° MEDIUM | 5 | 1 min | Identifies 80% of health determinants |
| **Functional Status** | üü¢ LOW | 6 | 1 min | Strongest predictor of mortality (age 65+) |
| **Reproductive Health** | üü¢ LOW | 4 | 30 sec | Medication safety (pregnancy), menopause risk |
| **Substance Use (detailed)** | üü¢ LOW | 4 | 1-2 min | Addiction screening, infectious disease risk |

**If adding all recommended lists:**
- **Current form:** 5-10 minutes
- **With all additions:** 8-15 minutes (still under 20 min target)

**Recommendation:** Add medications as REQUIRED, consider SDOH and immunizations for comprehensive intake

---

<a name="free-text-strategy"></a>
## 8. FREE-TEXT REDUCTION STRATEGY

### Current Free-Text Fields in Mockup

| Section | Free-Text Field | Estimated Usage | Problem |
|---------|----------------|-----------------|---------|
| Medical History | "I have other medical conditions" | 10-15% of patients | Cannot auto-map to score modifiers |
| Family History | "Other family history" | 5-10% | No genetic risk stratification |
| Surgical History | "I have had other surgeries" | 10-15% | Cannot infer linked diagnoses |
| Allergies | "I have other allergies" | 5-10% | No EMR auto-alerts |
| Medications | Manual text entry (if not photo) | 30-40% (if photo disabled) | Misspellings, wrong doses |

**Total Patients Using Free-Text:** 30-50% will use at least ONE free-text field

**Problem:** Free-text requires:
1. ‚úçÔ∏è Manual clinical review (staff time)
2. üîç Manual coding (ICD-10, CPT, allergy codes)
3. üßÆ Manual score modifier assignment
4. ‚ö†Ô∏è Delays dashboard generation (not automated)

---

### STRATEGY 1: Expand Tier 1 Lists (Add More Checkboxes)

**Recommendation:** Add **Tier 1.5 - "Uncommon but Codeable" Items**

Instead of free-text, add expandable sections with less common but still structured items.

---

#### Example: Medical History Tier 1.5 (Add 30 More Conditions)

**Click "Show Less Common Conditions" to expand:**

| Condition | Prevalence | Why Add to Tier 1.5 |
|-----------|------------|---------------------|
| Sarcoidosis | 0.06% | Well-defined score modifiers (Resp-Function -8, Immune-Risk -6) |
| Hemochromatosis | 0.25% | Metabolic-Function -6, cirrhosis risk |
| Raynaud's phenomenon | 3-5% | Vascular disease marker, Cardio-Risk -4 |
| Interstitial lung disease | 0.07% | Resp-Function -15 |
| Pernicious anemia | 0.1% | Metabolic-Function -4 (B12 deficiency) |
| Peripheral neuropathy | 2-3% | Neuro-Function -8 (often diabetic, alcohol, or chemo-related) |
| Restless leg syndrome | 5-10% | Neuro-Function -3, sleep quality |
| Trigeminal neuralgia | 0.01% | Neuro-Function -6 (severe pain) |
| Hidradenitis suppurativa | 0.1% | Immune-Risk -5 (chronic inflammation) |
| Vitiligo | 0.5-1% | Immune-Risk -3 (autoimmune marker) |

**Benefit:**
- Captures another 10-15% of patients who would otherwise use free-text
- All items pre-coded with score modifiers
- No manual review needed

**Cost:**
- Adds 1 expandable click + 30 checkboxes
- ~30 seconds additional form time for patients with rare conditions

---

#### Example: Surgical History Tier 1.5 (Add 20 More Procedures)

**Click "Show Less Common Surgeries" to expand:**

| Surgery | Prevalence | Why Add |
|---------|------------|---------|
| Whipple procedure (pancreatic resection) | 10K/year | Cancer surgery, major malabsorption, Metabolic-Function -15 |
| Esophagectomy | 15K/year | Cancer, severe GERD surgery, Metabolic-Function -12 |
| Craniotomy (brain surgery) | 90K/year | Neuro-Structure -15, seizure risk |
| Parathyroidectomy | 35K/year | Hyperparathyroidism, calcium monitoring, Repro-Function -6 |
| Adrenalectomy | 10K/year | Adrenal tumor, hormone replacement, Repro-Function -10 |
| Nephrectomy (kidney removal) | 65K/year | Renal-Function -20 (one kidney) |
| Lobectomy (lung removal) | 40K/year | Resp-Function -15 |
| Gastric bypass (Roux-en-Y) | Covered under bariatric, but specific type matters | Different malabsorption than sleeve |
| Sleeve gastrectomy | Covered under bariatric | Less malabsorption than bypass |
| Fundoplication (GERD surgery) | 30K/year | Metabolic-Function -4, swallowing issues |

**Benefit:** Captures surgical patients who might otherwise write "stomach surgery" (too vague)

---

#### Example: Allergy Tier 1.5 (Add 15 More Allergies)

**Click "Show Less Common Allergies" to expand:**

| Allergy | Why Add |
|---------|---------|
| Specific biologics (Humira, Enbrel, Remicade) | Increasingly common for autoimmune diseases |
| Diuretics (furosemide, HCTZ) | Common for heart failure, BP |
| Anticoagulants (warfarin, heparin) | Critical for clot prevention |
| Allopurinol | Gout medication, severe reactions (DRESS syndrome) possible |
| Lamotrigine | Seizure med, severe rash risk (Stevens-Johnson) |
| Vancomycin | Hospital antibiotic, "red man syndrome" |
| Muscle relaxants (cyclobenzaprine) | Common for back pain |
| Benzodiazepines (Xanax, Ativan) | Anxiety/sleep meds |
| SSRIs (Prozac, Zoloft) | Depression/anxiety, common |
| PPIs (omeprazole, Nexium) | GERD medications |
| Sesame | 9th FDA allergen (newly added 2023) |
| Insect stings (bee/wasp) | Anaphylaxis risk, EpiPen needed |
| Nickel | Contact dermatitis, jewelry/implant considerations |
| Formaldehyde | Preservative in cosmetics, vaccines |
| Fragrance/perfume | Common contact allergen |

---

### STRATEGY 2: Intelligent Free-Text Parsing (NLP)

**For remaining free-text entries, use Natural Language Processing to auto-suggest structured items**

**Example Workflow:**

1. **Patient types:** "I had my gallbladder out"
2. **NLP algorithm detects:** Keywords "gallbladder" + "out"/"removed"
3. **System suggests:**
   ```
   Did you mean:
   ‚òê Gallbladder removal (cholecystectomy)

   If yes, click here instead of typing.
   If no, continue with your description.
   ```
4. **Patient clicks checkbox** ‚Üí Auto-codes as "Gallbladder removal" with standard score modifiers
5. **Saves manual coding time**

**Common Patterns to Auto-Detect:**

| Patient Writes | NLP Detects | Auto-Suggest |
|----------------|-------------|--------------|
| "heart surgery" | "heart" + "surgery" | Checkbox options: CABG / Valve / Stent / Pacemaker |
| "thyroid removed" | "thyroid" + "removed" | Thyroidectomy checkbox |
| "stomach stapling" | "stomach" + "stapling"/"bypass"/"surgery" | Bariatric surgery checkbox |
| "breast removed" | "breast" + "removed" | Mastectomy checkbox |
| "allergic to PCN" | "PCN"/"penicillin" | Penicillin allergy checkbox |
| "diabetic medication" | "diabetic"/"diabetes" + "medication" | Metformin / Insulin checkboxes |

**Benefit:**
- Reduces true free-text by 50-70%
- Patients get immediate feedback ("Yes, that's what I meant!")
- Auto-coding for score modifiers

**Tech Requirements:**
- Medical NLP library (e.g., AWS Comprehend Medical, Google Healthcare NLP)
- Custom keyword dictionary (500-1000 common medical terms + slang)

---

### STRATEGY 3: Smart Dropdown Menus Instead of Free-Text

**For common free-text categories, replace with searchable dropdowns**

**Example: "Other Medical Conditions" Dropdown**

Instead of free-text box:
```
I have other medical conditions (please describe):
[________________________________________]
```

Use searchable dropdown:
```
I have other medical conditions:

[Start typing condition name...  ‚ñº]

(Dropdown shows: All 132 Tier 1 + 30 Tier 1.5 + 200 Tier 2 conditions)

Type "sarcoid" ‚Üí Shows "Sarcoidosis"
Type "lupus" ‚Üí Shows "Systemic Lupus Erythematosus"
Type "gout" ‚Üí Shows "Gout"
```

**Benefit:**
- Patient starts typing, sees structured options
- Reduces misspellings
- Auto-codes if they select from dropdown

**Tier 2 Library (200 Additional Conditions):**
Create a background database of 200 more conditions (less common, but still codeable) that appear in searchable dropdown.

Examples:
- Sarcoidosis, Raynaud's, peripheral neuropathy (Tier 1.5 candidates)
- Ehlers-Danlos syndrome, Marfan syndrome, sickle cell trait
- Hidradenitis suppurativa, vitiligo, rosacea
- Meniere's disease, tinnitus, Bell's palsy

All pre-coded with score modifiers.

---

### STRATEGY 4: Clinical Review Workflow for True Free-Text

**For the remaining 5-10% of patients with truly rare/unlisted conditions:**

**Workflow:**

1. Patient submits form with free-text entry
2. Dashboard generates with note: "‚ö†Ô∏è Manual review required - clinical staff will review within 1-2 business days"
3. Clinical staff reviews free-text, assigns:
   - ICD-10 code
   - Score modifiers (or uses default Tier 2 modifiers)
   - Monitoring needs
4. Dashboard updates with finalized scores
5. **Learning Loop:** If same condition reported by 3+ patients ‚Üí Add to Tier 1.5 or Tier 2 dropdown

**Default Tier 2 Score Modifiers (when specific condition not in library):**

| Condition Category | Default Modifier |
|--------------------|------------------|
| Rare neurological | -10 Neuro-Function |
| Rare autoimmune | -8 Immune-Risk |
| Rare genetic | -5 to relevant system |
| Rare cancer | -10 Immune-Risk |
| Benign/minor condition | -2 to relevant system |

**Timeline:**
- Patient sees preliminary dashboard immediately (without free-text conditions scored)
- Clinical review within 1-2 business days
- Updated dashboard emailed to patient

---

<a name="free-text-conversion"></a>
## 9. CONVERTING FREE-TEXT TO STRUCTURED DATA

### Conversion Strategy Overview

**Goal:** Every free-text entry eventually becomes a checkbox (continuous improvement)

**Method:** Quarterly review of free-text entries ‚Üí Add common ones to Tier 1.5

---

### Step-by-Step Conversion Process

#### STEP 1: Capture & Categorize All Free-Text

**Database Table: `free_text_entries`**

| Field | Purpose |
|-------|---------|
| `entry_text` | Exact patient text |
| `section` | Medical history / Family history / Surgery / Allergy |
| `frequency_count` | How many patients entered similar text |
| `clinical_code` | ICD-10 / CPT / Allergen code (assigned by reviewer) |
| `score_modifier` | Assigned modifier after clinical review |
| `status` | Pending / Reviewed / Approved for Tier 1.5 |

---

#### STEP 2: Quarterly Analysis (Data-Driven Tier 1.5 Expansion)

**Every 3 months, run report:**

```sql
SELECT entry_text, COUNT(*) as frequency
FROM free_text_entries
WHERE section = 'medical_history'
AND status = 'reviewed'
GROUP BY entry_text
HAVING COUNT(*) >= 3
ORDER BY COUNT(*) DESC
```

**Example Output:**

| Free-Text Entry | Frequency | Recommended Action |
|-----------------|-----------|-------------------|
| "sarcoidosis" | 12 patients | ‚úÖ Add to Tier 1.5 Medical History |
| "brain surgery" | 8 patients | ‚úÖ Add "Craniotomy" to Tier 1.5 Surgical |
| "allergic to shellac" | 6 patients | ‚úÖ Add to Tier 1.5 Allergies |
| "peripheral neuropathy" | 15 patients | ‚úÖ Add to Tier 1.5 Medical History |
| "whipple procedure" | 5 patients | ‚úÖ Add to Tier 1.5 Surgical |
| "rare genetic syndrome XYZ" | 1 patient | ‚è∏Ô∏è Keep in Tier 2 (too rare) |

---

#### STEP 3: Clinical Review & Score Modifier Assignment

**For each new Tier 1.5 candidate:**

1. **Assign ICD-10 code** (for insurance billing, diagnosis tracking)
2. **Research clinical impact** (literature review, clinical guidelines)
3. **Assign score modifiers** (which of 24 cells affected, magnitude)
4. **Create smart expansion questions** (if applicable)
5. **Add to library**

**Example: Sarcoidosis (appeared 12 times in free-text)**

**Clinical Research:**
- ICD-10: D86.9 (Sarcoidosis, unspecified)
- Prevalence: 0.06% US adults (140K patients)
- Mortality: 1-5% (pulmonary complications)
- Affected systems: Lungs (90%), lymph nodes (90%), skin (25%), eyes (25%)

**Score Modifiers:**
- Respiratory-Function: **-8 points** (restrictive lung disease)
- Respiratory-Structure: **-6 points** (granulomas)
- Immune-Risk: **-6 points** (immune dysregulation)
- Cardiovascular-Risk: **-4 points** (cardiac sarcoid in 5%)

**Smart Expansion Questions:**
1. Which organs are affected? (Check all: Lungs / Lymph nodes / Skin / Eyes / Heart / Other)
2. Are you on treatment? (No treatment / Prednisone / Immunosuppressants / Remission)

**Add to Library:**
- Medical History Tier 1.5, Priority 2
- Patient-friendly label: "Sarcoidosis (inflammatory disease affecting lungs or other organs)"

---

#### STEP 4: Update Intake Form (Add to Tier 1.5 Expandable Section)

**Modify intake form:**

```
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ

          [‚ñº Click here to see other common conditions]

‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ

[Section expands to show Tier 1.5 conditions including:]

‚ñ° Sarcoidosis (inflammatory disease affecting lungs or other organs)  ‚Üê NEWLY ADDED
‚ñ° Peripheral neuropathy (nerve damage causing numbness/tingling)      ‚Üê NEWLY ADDED
‚ñ° Raynaud's phenomenon (fingers turn white/blue in cold)
‚ñ° Interstitial lung disease
...
```

---

#### STEP 5: Continuous Improvement Loop

**Timeline:**

| Quarter | Action |
|---------|--------|
| **Q1** | Launch intake form with 132 Tier 1 conditions |
| **Q2** | Analyze 3 months of free-text data ‚Üí Add 10-15 conditions to Tier 1.5 |
| **Q3** | Analyze 3 more months ‚Üí Add another 10-15 conditions |
| **Q4** | Analyze 3 more months ‚Üí Add another 10-15 conditions |
| **Year 2** | Tier 1 + Tier 1.5 now covers 95%+ of patients (vs. 85% initially) |

**Expected Reduction in Free-Text Usage:**

| Timepoint | Free-Text Usage |
|-----------|-----------------|
| **Launch (Q1)** | 30-50% of patients use at least one free-text field |
| **After Q2 update** | 20-35% (added 15 common Tier 1.5 items) |
| **After Q3 update** | 15-25% |
| **After Q4 update** | 10-15% |
| **Year 2+** | <10% (only truly rare conditions) |

---

### Machine Learning Enhancement (Future Phase)

**Once you have 500+ free-text entries with clinical codes:**

Train a machine learning model to:

1. **Auto-suggest ICD-10 codes** for new free-text entries
   - Input: "I have a rare lung disease called sarcoidosis"
   - Model predicts: D86.9 (Sarcoidosis) with 95% confidence
   - Staff reviewer confirms or corrects

2. **Auto-assign score modifiers**
   - Model learns: Sarcoidosis ‚Üí Resp-Function -8, Immune-Risk -6
   - Reduces manual clinical review time by 70%

3. **Auto-detect duplicates**
   - Patient writes "sarcoid" vs. "sarcoidosis" vs. "sarc"
   - Model recognizes all as same condition

**Tech Stack:**
- NLP: BioBERT, ClinicalBERT (medical language models)
- Training data: Your own coded free-text entries (gold standard)
- Accuracy target: 90%+ for common conditions, 70%+ for rare

---

## üìä SUMMARY: FREE-TEXT REDUCTION ROADMAP

| Strategy | Reduction Impact | Implementation Difficulty | Timeline |
|----------|------------------|---------------------------|----------|
| **1. Expand Tier 1.5** (add 30-50 items) | -30% free-text | LOW (just add checkboxes) | Q2 |
| **2. NLP Auto-Suggest** | -20% free-text | MEDIUM (NLP integration) | Q3 |
| **3. Searchable Dropdowns** (Tier 2 library) | -15% free-text | LOW-MEDIUM (dropdown UI) | Q2 |
| **4. Quarterly Review Loop** | -10% free-text/quarter | LOW (manual process) | Ongoing |
| **5. Machine Learning** | -20% clinical review time | HIGH (ML model training) | Year 2 |

**Total Reduction: 30-50% free-text usage ‚Üí <10% by end of Year 1**

---

## üéØ FINAL RECOMMENDATIONS

### For Immediate Implementation (Next 30 Days):

1. ‚úÖ **Use current libraries as-is** (132 medical, 15 family, 40 surgical, 31 allergy)
2. ‚úÖ **Accept 30-50% free-text usage initially** (this is normal for comprehensive intake)
3. ‚úÖ **Implement photo upload for medications** (eliminates 70% of medication free-text)
4. ‚úÖ **Create clinical review workflow** for free-text entries (1-2 business day turnaround)

### For 3-Month Updates (Q2):

1. üìã **Analyze first 100-200 patient submissions** ‚Üí Identify top 15 free-text entries
2. üìã **Create Tier 1.5 expandable sections** with these 15 items
3. üìã **Add searchable dropdown** for "Other" fields (Tier 2 library of 200 conditions)
4. üìã **Add SDOH questions** (5 questions, 1 minute)
5. üìã **Add immunization history** (8 questions, 1-2 minutes)

### For 6-12 Month Enhancements (Q3-Q4):

1. ü§ñ **Implement NLP auto-suggest** for free-text fields
2. ü§ñ **Add functional status** for age 65+ (6 questions)
3. ü§ñ **Add detailed substance use** (AUDIT-C, NIDA Quick Screen)
4. ü§ñ **Add reproductive health** for women (4 questions)
5. ü§ñ **Continuous Tier 1.5 expansion** based on quarterly data

### For Year 2+:

1. üöÄ **Machine learning auto-coding** for remaining free-text
2. üöÄ **Predictive intake** (pre-populate based on demographics, zip code epidemiology)
3. üöÄ **Voice-to-text intake** option for low-literacy patients

---

**Document Status:** ‚úÖ Complete
**Last Updated:** November 25, 2025
**Next Steps:** Review with clinical team, finalize production-ready form specifications

---

*This document provides complete clinical rationale for every decision in the intake form design, supporting evidence-based patient care and efficient data capture.*
